SEC Form EFFECT filed by Opiant Pharmaceuticals Inc.
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | March 9, 2023 |
Accession Number: | 0001385508-23-000095 | ||||||
Submission Type: | POS AM | ||||||
|